BRINZOLAMIDE and BLINDNESS

Overview

BLINDNESS is the #13 most commonly reported adverse reaction for BRINZOLAMIDE, manufactured by Sandoz Inc. There are 361 FDA adverse event reports linking BRINZOLAMIDE to BLINDNESS. This represents approximately 1.7% of all 21,426 adverse event reports for this drug.

Patients taking BRINZOLAMIDE who experience blindness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

BLINDNESS is a less commonly reported adverse event for BRINZOLAMIDE, but still significant enough to appear in the safety profile.

Other Side Effects of BRINZOLAMIDE

In addition to blindness, the following adverse reactions have been reported for BRINZOLAMIDE:

• TREATMENT FAILURE — 1,429 reports
• DYSPNOEA — 564 reports
• DRUG INEFFECTIVE — 499 reports
• DIZZINESS — 479 reports
• EYE PAIN — 468 reports
• DIARRHOEA — 459 reports
• FATIGUE — 454 reports
• FALL — 433 reports
• HEADACHE — 426 reports
• VISION BLURRED — 418 reports

Other Drugs Associated with BLINDNESS

The following drugs have also been linked to blindness in FDA adverse event reports:

Does BRINZOLAMIDE cause BLINDNESS?

BLINDNESS has been reported as an adverse event in 361 FDA reports for BRINZOLAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is BLINDNESS with BRINZOLAMIDE?

BLINDNESS accounts for approximately 1.7% of all adverse event reports for BRINZOLAMIDE, making it a notable side effect.

What should I do if I experience BLINDNESS while taking BRINZOLAMIDE?

If you experience blindness while taking BRINZOLAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages